These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
254 related items for PubMed ID: 10526902
1. Low dose of eicosapentaenoic acid inhibits the exaggerated growth of vascular smooth muscle cells from spontaneously hypertensive rats through suppression of transforming growth factor-beta. Nakayama M, Fukuda N, Watanabe Y, Soma M, Hu WY, Kishioka H, Satoh C, Kubo A, Kanmatsuse K. J Hypertens; 1999 Oct; 17(10):1421-30. PubMed ID: 10526902 [Abstract] [Full Text] [Related]
2. Role of endogenous angiotensin II in the increased expression of growth factors in vascular smooth muscle cells from spontaneously hypertensive rats. Satoh C, Fukuda N, Hu WY, Nakayama M, Kishioka H, Kanmatsuse K. J Cardiovasc Pharmacol; 2001 Jan; 37(1):108-18. PubMed ID: 11152368 [Abstract] [Full Text] [Related]
3. Troglitazone inhibits growth and improves insulin signaling by suppression of angiotensin II action in vascular smooth muscle cells from spontaneously hypertensive rats. Fukuda N, Hu WY, Teng J, Chikara S, Nakayama M, Kishioka H, Kanmatsuse K. Atherosclerosis; 2002 Aug; 163(2):229-39. PubMed ID: 12052469 [Abstract] [Full Text] [Related]
4. Effects of the L- and N-type calcium channel blocker cilnidipine on growth of vascular smooth muscle cells from spontaneously hypertensive rats. Hu WY, Fukuda N, Su JZ, Kanmatsuse K. J Cardiovasc Pharmacol; 2001 Sep; 38(3):450-9. PubMed ID: 11486249 [Abstract] [Full Text] [Related]
5. Angiotensin II regulates the cell cycle of vascular smooth muscle cells from SHR. Kubo A, Fukuda N, Teng J, Satoh C, Nakayama M, Kishioka H, Kanmatsuse K. Am J Hypertens; 2000 Oct; 13(10):1117-24. PubMed ID: 11041167 [Abstract] [Full Text] [Related]
6. Contribution of synthetic phenotype on the enhanced angiotensin II-generating system in vascular smooth muscle cells from spontaneously hypertensive rats. Fukuda N, Hu WY, Satoh C, Nakayama M, Kishioka H, Kubo A, Kanmatsuse K. J Hypertens; 1999 Aug; 17(8):1099-107. PubMed ID: 10466465 [Abstract] [Full Text] [Related]
7. Antisense oligodeoxynucleotide complementary to platelet-derived growth factor A-chain messenger RNA inhibits the arterial proliferation in spontaneously hypertensive rats without altering their blood pressures. Fukuda N, Kubo A, Watanabe Y, Nakayama T, Soma M, Izumi Y, Kanmatsuse K. J Hypertens; 1997 Oct; 15(10):1123-36. PubMed ID: 9350586 [Abstract] [Full Text] [Related]
9. Abnormal regulation of transforming growth factor-beta receptors on vascular smooth muscle cells from spontaneously hypertensive rats by angiotensin II. Fukuda N, Hu WY, Kubo A, Endoh M, Kishioka H, Satoh C, Soma M, Izumi Y, Kanmatsuse K. Hypertension; 1998 Feb; 31(2):672-7. PubMed ID: 9461239 [Abstract] [Full Text] [Related]
13. Inhibitory effect of a novel angiotensin II type 1 receptor antagonist RNH-6270 on growth of vascular smooth muscle cells from spontaneously hypertensive rats: different anti-proliferative effect to angiotensin-converting enzyme inhibitor. Teng J, Fukuda N, Suzuki R, Takagi H, Ikeda Y, Tahira Y, Kanmatsuse K. J Cardiovasc Pharmacol; 2002 Feb; 39(2):161-71. PubMed ID: 11791001 [Abstract] [Full Text] [Related]
15. Transforming growth factor-beta 1 proliferated vascular smooth muscle cells from spontaneously hypertensive rats. Sato M, Ohsaki Y, Tobise K. Am J Hypertens; 1995 Feb; 8(2):160-6. PubMed ID: 7755944 [Abstract] [Full Text] [Related]
16. The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats. Rosen B, Barg J, Zimlichman R. Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1243-51. PubMed ID: 10619588 [Abstract] [Full Text] [Related]